DNA Firm Oxford Nanopore Plans $649 Million London IPO

Deal values the sequencing startup at up to 3.8 billion pounds
Startup adds to growing list of tech-related listings in U.K.

Source: Oxford Nanopore Technologies Ltd.,

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Swetha Gopinath and Marthe Fourcade

September 23, 2021 at 6:12 AM UTC

Updated on

September 23, 2021 at 7:26 AM UTC

This article is for subscribers only.

Follow us at @BloombergUK for the latest news and analysis.

Oxford Nanopore Technologies Ltd., the DNA-sequencing company, plans an initial public offering that could raise as much as 476 million pounds ($649 million), capitalizing on the success of its pandemic work to fund future growth.